← Leaderboards
Reza Abdi
Brigham And Women'S Hospital
$32,829,278
Attributed
$32,829,278
Total exposure
21
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.6M · FY2011–25$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,930,429 · 23
By mechanism
P01$19,485,137 · 11
R01$16,622,321 · 7
R35$3,118,293 · 1
U01$2,334,750 · 1
K24$1,394,808 · 1
R56$975,120 · 2
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Markus H. Frank$10,452,698
- Natasha Y Frank$4,964,719
- George F Murphy$7,377,470
- Robert Sackstein$20,708,410
- Stefan Gunther Tullius$7,768,739
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteTransplantationInnovationImmuneAllograft RejectionEquilibriumResponseInflammatoryOrgan TransplantationRegulatory T-LymphocyteLymph NodesTargeted DeliveryOrganPlayAlloantigenNanoparticleMediatingPreventCellsGraft RejectionPathogenesisHeart TransplantationImmunoregulationIsoimmunity
Grant awards (81)
Aging and transplant immunity$2,363,918
P01 · FY2025 · AI · contact PI
Targeted immune therapies in heart transplantation$1,039,260
R35 · FY2025 · HL · contact PI
Lymph Node Delivery in Transplantation$926,000
U01 · FY2025 · AI · contact PI
Project 2 - BWH$849,884
P01 · FY2025 · AI · contact PI
The novel role of beta3 integrin in regulating alloimmunity$727,003
R01 · FY2025 · AI · contact PI
New way in delivering immunomodulatory drugs in T1D$597,624
R01 · FY2025 · AI · contact PI
Lymph node stromal senescence and transplant immunity$596,444
P01 · FY2025 · AI · contact PI
IRI, innate immunity and transplant rejection$434,700
R01 · FY2025 · AI · contact PI
Nanotechnology Core C$390,243
P01 · FY2025 · AI · contact PI
Core B - BWH Nanoparticle Core$352,599
P01 · FY2025 · AI · contact PI
Administrative Core$158,954
P01 · FY2025 · AI · contact PI
Nano Immune-Imaging Core$158,953
P01 · FY2025 · AI · contact PI
Aging and transplant immunity$2,369,758
P01 · FY2024 · AI · contact PI
Lymph nodes at the crossroads of allo immunity and regulation$1,269,545
P01 · FY2024 · AI · contact PI
Targeted immune therapies in heart transplantation$1,028,140
R35 · FY2024 · HL · contact PI
The novel role of beta3 integrin in regulating alloimmunity$749,489
R01 · FY2024 · AI · contact PI
Project 2 - BWH$647,180
P01 · FY2024 · AI · contact PI
New way in delivering immunomodulatory drugs in T1D$616,107
R01 · FY2024 · AI · contact PI
Lymph node stromal senescence and transplant immunity$588,282
P01 · FY2024 · AI · contact PI
HVEM pathway regulating FRC function and transplant tolerance$511,721
P01 · FY2024 · AI · contact PI
Lymph Node Delivery in Transplantation$463,000
U01 · FY2024 · AI · contact PI
IRI, innate immunity and transplant rejection$448,146
R01 · FY2024 · AI · contact PI
Core B - BWH Nanoparticle Core$268,500
P01 · FY2024 · AI · contact PI
Core B$176,467
P01 · FY2024 · AI · contact PI
Nano Immune-Imaging Core$174,026
P01 · FY2024 · AI · contact PI
Administrative Core$156,126
P01 · FY2024 · AI · contact PI
Admin Core$117,857
P01 · FY2024 · AI · contact PI
Lymph nodes at the crossroads of allo immunity and regulation$1,269,545
P01 · FY2023 · AI · contact PI
Targeted immune therapies in heart transplantation$1,050,893
R35 · FY2023 · HL · contact PI
The novel role of beta3 integrin in regulating alloimmunity$761,302
R01 · FY2023 · AI · contact PI
New way in delivering immunomodulatory drugs in T1D$616,107
R01 · FY2023 · AI · contact PI
HVEM pathway regulating FRC function and transplant tolerance$520,500
P01 · FY2023 · AI · contact PI
Lymph Node Delivery in Transplantation$463,000
U01 · FY2023 · AI · contact PI
IRI, innate immunity and transplant rejection$457,091
R01 · FY2023 · AI · contact PI
Core B$179,411
P01 · FY2023 · AI · contact PI
Developing novel biomarkers of renal transplant rejection$152,226
K24 · FY2023 · AI · contact PI
Admin Core$118,704
P01 · FY2023 · AI · contact PI
Lymph nodes at the crossroads of allo immunity and regulation$1,269,545
P01 · FY2022 · AI · contact PI
The novel role of beta3 integrin in regulating alloimmunity$777,134
R01 · FY2022 · AI · contact PI
New way in delivering immunomodulatory drugs in T1D$635,857
R01 · FY2022 · AI · contact PI
A novel approach to delivering therapeutics in heart transplantation$562,730
R01 · FY2022 · HL · contact PI
HVEM pathway regulating FRC function and transplant tolerance$511,721
P01 · FY2022 · AI · contact PI
Lymph Node Delivery in Transplantation$482,750
U01 · FY2022 · AI · contact PI
IRI, innate immunity and transplant rejection$463,418
R01 · FY2022 · AI · contact PI
Core B$176,467
P01 · FY2022 · AI · contact PI
Developing novel biomarkers of renal transplant rejection$152,226
K24 · FY2022 · AI · contact PI
Admin Core$117,857
P01 · FY2022 · AI · contact PI
Lymph nodes at the crossroads of allo immunity and regulation$1,269,545
P01 · FY2021 · AI · contact PI
A novel approach to delivering therapeutics in heart transplantation$692,505
R01 · FY2021 · HL · contact PI
HVEM pathway regulating FRC function and transplant tolerance$511,721
P01 · FY2021 · AI · contact PI
IRI, innate immunity and transplant rejection$463,436
R01 · FY2021 · AI · contact PI
PI3K-gamma regulates T cell mediated alloimmunity$392,516
R01 · FY2021 · HL · contact PI
Core B$176,467
P01 · FY2021 · AI · contact PI
Developing novel biomarkers of renal transplant rejection$152,226
K24 · FY2021 · AI · contact PI
Admin Core$117,857
P01 · FY2021 · AI · contact PI
Lymph nodes at the crossroads of allo immunity and regulation$1,289,295
P01 · FY2020 · AI · contact PI
A novel approach to delivering therapeutics in heart transplantation$692,505
R01 · FY2020 · HL · contact PI
Targeted nanodelivery in T1D$570,859
R56 · FY2020 · AI · contact PI
Protection of organ transplant from ischemia reperfusion injuries$514,147
R01 · FY2020 · AI · contact PI
HVEM pathway regulating FRC function and transplant tolerance$511,721
P01 · FY2020 · AI · contact PI
PI3K-gamma regulates T cell mediated alloimmunity$392,516
R01 · FY2020 · HL · contact PI
Determining the genetic and diagnostic markers of acute renal allograft rejection$187,626
K24 · FY2020 · AI · contact PI
Core B$176,467
P01 · FY2020 · AI · contact PI
Admin Core$117,857
P01 · FY2020 · AI · contact PI
A novel approach to delivering therapeutics in heart transplantation$692,505
R01 · FY2019 · HL · contact PI
Protection of organ transplant from ischemia reperfusion injuries$514,147
R01 · FY2019 · AI · contact PI
PI3K-gamma regulates T cell mediated alloimmunity$392,516
R01 · FY2019 · HL · contact PI
Determining the genetic and diagnostic markers of acute renal allograft rejection$187,626
K24 · FY2019 · AI · contact PI
Protection of organ transplant from ischemia reperfusion injuries$514,147
R01 · FY2018 · AI · contact PI
PI3K-gamma regulates T cell mediated alloimmunity$392,516
R01 · FY2018 · HL · contact PI
Determining the genetic and diagnostic markers of acute renal allograft rejection$187,626
K24 · FY2018 · AI · contact PI
Protection of organ transplant from ischemia reperfusion injuries$518,498
R01 · FY2017 · AI · contact PI
Determining the genetic and diagnostic markers of acute renal allograft rejection$187,626
K24 · FY2017 · AI · contact PI
Protection of organ transplant from ischemia reperfusion injuries$548,546
R01 · FY2016 · AI · contact PI
The novel role of the PI3Kγ and δ pathways in alloimmunity$404,261
R56 · FY2016 · AI · contact PI
Determining the genetic and diagnostic markers of acute renal allograft rejection$187,626
K24 · FY2016 · AI · contact PI
Ischemia-reperfusion injury in transplantation: novel cytoprotection strategies$420,345
R01 · FY2015 · AI · contact PI
Ischemia-reperfusion injury in transplantation: novel cytoprotection strategies$417,990
R01 · FY2014 · AI · contact PI
Ischemia-reperfusion injury in transplantation: novel cytoprotection strategies$392,911
R01 · FY2013 · AI · contact PI
Ischemia-reperfusion injury in transplantation: novel cytoprotection strategies$414,458
R01 · FY2012 · AI · contact PI
Ischemia-reperfusion injury in transplantation: novel cytoprotection strategies$409,409
R01 · FY2011 · AI · contact PI